Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership448,371 shares
Latest Disclosed Value $ 346,429,369
Bnp Paribas Arbitrage, Sa ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 448,371 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $346,429,369 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 440,844 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 1.71% during the quarter.

Bnp Paribas Arbitrage, Sa has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 47 of underlying shares valued at $3,631,408 USD and put options representing 40 of underlying shares valued at $3,090,560 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Regeneron Pharmaceuticals Equity 75886F107 448,371 7,527 1.71 346,429 1.81 0.0172
2026-02-10 2025-12-31 13F Regeneron Pharmaceuticals Equity 75886F107 440,844 -36,808 -7.71 340,274 26.70 0.1542
2025-11-13 2025-09-30 13F Regeneron Pharmaceuticals Equity 75886F107 477,652 -46,706 -8.91 268,569 -2.44 0.1434
2025-08-14 2025-06-30 13F Regeneron Pharmaceuticals Equity 75886F107 524,358 -222,255 -29.77 275,288 -41.86 0.1578
2025-05-14 2025-03-31 13F Regeneron Pharmaceuticals Equity 75886F107 746,613 207,017 38.37 473,524 23.19 0.2785
2025-02-14 2024-12-31 13F Regeneron Pharmaceuticals Equity 75886F107 539,596 244,184 82.66 384,370 23.77 0.2154
2024-11-13 2024-09-30 13F Regeneron Pharmaceuticals Equity 75886F107 295,412 48,721 19.75 310,549 19.77 0.2087
2024-08-13 2024-06-30 13F Regeneron Pharmaceuticals Equity 75886F107 246,691 6,867 2.86 259,280 12.33 0.2113
2024-05-01 2024-03-31 13F Regeneron Pharmaceuticals Equity 75886F107 239,824 24,286 11.27 230,828 21.94 0.2027
2024-02-14 2023-12-31 13F/A-2 Regeneron Pharmaceuticals Equity 75886F107 215,538 30,432 16.44 189,305 24.27 0.2149
2024-02-07 2023-12-31 13F/A-1 Regeneron Pharmaceuticals Equity 75886F107 214,108 29,002 188,049 0.0265
2024-02-07 2023-12-31 13F Regeneron Pharmaceuticals Equity 75886F107 214,108 29,002 188,049 0.0265
2023-11-14 2023-09-30 13F Regeneron Pharmaceuticals Equity 75886F107 185,106 33,903 22.42 152,335 40.21 0.1957
2023-08-09 2023-06-30 13F Regeneron Pharmaceuticals Equity 75886F107 151,203 41,165 37.41 108,645 20.16 0.1359
2023-05-12 2023-03-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 110,038 9,640 9.60 90,415 24.82 0.1267
2023-02-14 2022-12-31 13F Regeneron Pharmaceuticals Equity 75886F107 100,398 15,401 18.12 72,436 23.71 0.1113
2022-11-16 2022-09-30 13F/A-1 Regeneron Pharmaceuticals Equity 75886F107 84,997 -7,260 -7.87 58,552 7.36 0.0937
2022-11-15 2022-09-30 13F Regeneron Pharmaceuticals Equity 75886F107 84,997 -7,260 58,552 0.0141
2022-08-12 2022-06-30 13F Regeneron Pharmaceuticals Equity 75886F107 92,257 25,417 38.03 54,536 16.82 0.0851
2022-05-18 2022-03-31 13F/A-1 Regeneron Pharmaceuticals Equity 75886F107 66,840 -16,543 -19.84 46,682 -11.35 0.0628
2022-02-09 2021-12-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 83,383 34,116 69.25 52,658 76.62 0.0750
2021-11-16 2021-09-30 13F/A-1 REGENERON PHARMACEUTICALS EQUITY 75886F107 49,267 -31,315 -38.86 29,815 -33.76 0.0423
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 132,428 51,846 74,131 0.0000
2021-08-10 2021-06-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 80,582 6,611 8.94 45,008 28.60 0.0596
2021-05-07 2021-03-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 73,971 -5,035 -6.37 34,999 -8.31 0.0512
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 79,006 -53,422 -40.34 38,169 -48.51 0.0710
2020-10-30 2020-09-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 132,428 61,981 87.98 74,131 68.73 0.1061
2020-08-06 2020-06-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 70,447 -5,172 -6.84 43,934 18.98 0.0775
2020-05-13 2020-03-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 75,619 32,005 73.38 36,924 125.48 0.0757
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 43,614 -104,383 -70.53 16,376 -60.11 0.0298
2019-11-07 2019-09-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 147,997 -36,503 -19.78 41,054 -28.91 0.0729
2019-07-30 2019-06-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 184,500 133,928 264.83 57,748 178.10 0.1151
2019-04-25 2019-03-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 50,572 -202,439 -80.01 20,766 -78.03 0.0449
2019-02-12 2018-12-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 253,011 -76,963 -23.32 94,500 -29.12 0.2232
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 329,974 -13,129 -3.83 133,323 12.63 0.1968
2018-07-25 2018-06-30 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 343,103 -6,124 -1.75 118,367 -1.57 0.1970
2018-05-11 2018-03-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 349,227 -146,503 -29.55 120,260 -35.47 0.2252
2018-03-05 2017-12-31 13F/A-1 REGENERON PHARMACEUTICALS EQUITY 75886F107 495,730 19,926 4.19 186,375 -12.39 0.3304
2018-02-01 2017-12-31 13F REGENERON PHARMACEUTICALS EQUITY 75886F107 495,730 19,926 186,375
2017-11-03 2017-09-30 13F REGENERON PHARMACEUTICALS STOCK 75886F107 475,804 50,627 11.91 212,741 1.88 0.5198
2017-08-03 2017-06-30 13F REGENERON PHARMACEUTICALS STOCK 75886F107 425,177 -108,066 -20.27 208,821 1.06 0.6298
2017-05-03 2017-03-31 13F REGENERON PHARMACEUTICALS STOCK 75886F107 533,243 465,801 690.67 206,637 734.66 0.5458
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS STOCK 75886F107 67,442 -1,226 -1.79 24,757 -10.32 0.1160
2016-10-05 2016-09-30 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 68,668 27,576 67.11 27,606 92.37 0.1136
2016-07-06 2016-06-30 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 41,092 -31,483 -43.38 14,351 -45.14 0.0647
2016-04-22 2016-03-31 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 72,575 43,424 148.96 26,159 65.30 0.1106
2016-04-19 2015-12-31 13F/A-1 * REGENERON PHARMACEUTICALS COM STOCK 75886F107 29,151 -6,341 -17.87 15,825 -4.14 0.0770
2016-02-10 2015-12-31 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 29,139 15,819
2015-11-13 2015-09-30 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 35,492 -10,222 -22.36 16,509 -29.21 0.0414
2015-08-14 2015-06-30 13F REGENERON PHARMACEUTICALS COM STOCK 75886F107 45,714 -49,975 -52.23 23,320 -46.02 0.0651
2015-05-15 2015-03-31 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 95,689 10,158 11.88 43,202 23.12 0.1196
2015-03-10 2014-12-31 13F/A-1 * REGENERON PHARMACEUTICALS COM STOCK 75886F107 85,531 -3,605 -4.04 35,089 9.19 0.1244
2015-02-11 2014-12-31 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 85,531 35,089
2014-11-12 2014-09-30 13F * REGENERON PHARMACEUTICALS COM STOCK 75886F107 89,136 33,004 58.80 32,135 102.68 0.0280
2014-08-14 2014-06-30 13F/A-1 * REGENERON PHARMACEUTICALS COM STOCK 75886F107 56,132 -41,537 -42.53 15,856 -45.32 0.0149
2014-08-14 2014-06-30 13F REGENERON PHARMACEUTICALS COM STOCK 75886F107 56,132 15,856
2014-05-13 2014-03-31 13F REGENERON PHARMACEUTICALS STOCK 75886F107 97,669 -63,684 -39.47 28,997 -34.71 0.0225
2014-04-02 2013-12-31 13F/A-1 REGENERON PHARMACEUTICALS STOCK 75886F107 161,353 5,807 3.73 44,411 -8.74 0.0324
2014-02-12 2013-12-31 13F REGENERON PHARMACEUTICALS STOCK 75886F107 161,353 44,411
2013-11-13 2013-09-30 13F REGENERON PHARMACEUTICALS STOCK 75886F107 155,546 88,949 133.56 48,666 224.95 0.0354
2013-08-13 2013-06-30 13F REGENERON PHARMACEUTICALS STOCK 75886F107 66,597 66,597 14,976 0.0106
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F Regeneron Pharmaceuticals Option Call 47 -38.16 3,631 -38.10 n/a n/a n/a
2026-02-10 2025-12-31 13F Regeneron Pharmaceuticals Option Call 76 24.59 5,866 71.07 n/a n/a n/a
2025-11-13 2025-09-30 13F Regeneron Pharmaceuticals Option Call 61 6,000.00 3,430 6,494.23 n/a n/a n/a
2025-08-14 2025-06-30 13F Regeneron Pharmaceuticals Option Call 1 -99.41 52 -99.51 n/a n/a n/a
2025-05-14 2025-03-31 13F Regeneron Pharmaceuticals Option Call 169 -51.01 10,718 -56.39 n/a n/a n/a
2025-02-14 2024-12-31 13F Regeneron Pharmaceuticals Option Call 345 0.29 24,575 -32.04 n/a n/a n/a
2024-11-13 2024-09-30 13F Regeneron Pharmaceuticals Option Call 344 -1.71 36,163 -1.70 n/a n/a n/a
2024-08-13 2024-06-30 13F Regeneron Pharmaceuticals Option Call 350 4.17 36,786 13.75 n/a n/a n/a
2024-05-01 2024-03-31 13F Regeneron Pharmaceuticals Option Call 336 -3.45 32,340 5.81 n/a n/a n/a
2024-02-14 2023-12-31 13F/A Regeneron Pharmaceuticals Option Call 348 17.17 30,564 25.05 n/a n/a n/a
2024-02-07 2023-12-31 13F/A Regeneron Pharmaceuticals Option Call 348 30,564 n/a n/a n/a
2024-02-07 2023-12-31 13F Regeneron Pharmaceuticals Option Call 348 30,564 n/a n/a n/a
2023-11-14 2023-09-30 13F Regeneron Pharmaceuticals Option Call 297 47.76 24,442 69.24 n/a n/a n/a
2023-08-09 2023-06-30 13F Regeneron Pharmaceuticals Option Call 201 -0.50 14,443 -12.98 n/a n/a n/a
2023-05-12 2023-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 202 -15.83 16,598 -4.15 n/a n/a n/a
2023-02-14 2022-12-31 13F Regeneron Pharmaceuticals Option Call 240 31.15 17,316 37.36 n/a n/a n/a
2022-11-16 2022-09-30 13F/A Regeneron Pharmaceuticals Option Call 183 -13.68 12,606 0.60 n/a n/a n/a
2022-11-15 2022-09-30 13F Regeneron Pharmaceuticals Option Call 183 12,606 n/a n/a n/a
2022-08-12 2022-06-30 13F Regeneron Pharmaceuticals Option Call 212 35.03 12,532 14.28 n/a n/a n/a
2022-05-18 2022-03-31 13F/A Regeneron Pharmaceuticals Option Call 157 1.95 10,965 12.75 n/a n/a n/a
2022-02-09 2021-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 154 9.22 9,725 13.97 n/a n/a n/a
2021-11-16 2021-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 141 0.00 8,533 8.36 n/a n/a n/a
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 370 20,712 n/a n/a n/a
2021-08-10 2021-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 141 -15.06 7,875 0.27 n/a n/a n/a
2021-05-07 2021-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 166 -59.21 7,854 -60.05 n/a n/a n/a
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 407 10.00 19,663 -5.06 n/a n/a n/a
2020-10-30 2020-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 370 65.18 20,712 48.26 n/a n/a n/a
2020-08-06 2020-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 224 -49.66 13,970 -35.71 n/a n/a n/a
2020-05-13 2020-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 445 -19.82 21,729 4.27 n/a n/a n/a
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 555 96.11 20,839 165.46 n/a n/a n/a
2019-11-07 2019-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 283 0.00 7,850 -11.37 n/a n/a n/a
2019-07-30 2019-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 283 56.35 8,858 19.17 n/a n/a n/a
2019-04-25 2019-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 181 -25.51 7,432 -18.11 n/a n/a n/a
2019-02-12 2018-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 243 0.00 9,076 -7.56 n/a n/a n/a
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 243 0.00 9,818 17.12 n/a n/a n/a
2018-07-25 2018-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 243 -99.00 8,383 0.19 n/a n/a n/a
2018-05-11 2018-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 24,300 -76.25 8,368 -78.24 n/a n/a n/a
2018-03-05 2017-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 102,300 11,726.59 38,461 3,062.83 n/a n/a n/a
2018-02-01 2017-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 102,300 38,461 n/a n/a n/a
2017-11-03 2017-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 865 -22.14 1,216 -66.58 n/a n/a n/a
2017-08-03 2017-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 1,111 203.55 3,640 340.02 n/a n/a n/a
2017-05-03 2017-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 366 -43.34 827 147.60 n/a n/a n/a
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 646 335 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F Regeneron Pharmaceuticals Option Put 40 -71.43 3,091 -71.40 n/a n/a n/a
2026-02-10 2025-12-31 13F Regeneron Pharmaceuticals Option Put 140 -28.21 10,806 -1.44 n/a n/a n/a
2025-11-13 2025-09-30 13F Regeneron Pharmaceuticals Option Put 195 -26.69 10,964 -21.49 n/a n/a n/a
2025-08-14 2025-06-30 13F Regeneron Pharmaceuticals Option Put 266 -61.28 13,965 -67.95 n/a n/a n/a
2025-05-14 2025-03-31 13F Regeneron Pharmaceuticals Option Put 687 -42.46 43,572 -48.77 n/a n/a n/a
2025-02-14 2024-12-31 13F Regeneron Pharmaceuticals Option Put 1,194 25.68 85,052 -14.83 n/a n/a n/a
2024-11-13 2024-09-30 13F Regeneron Pharmaceuticals Option Put 950 9.07 99,868 9.09 n/a n/a n/a
2024-08-13 2024-06-30 13F Regeneron Pharmaceuticals Option Put 871 -9.46 91,545 -1.13 n/a n/a n/a
2024-05-01 2024-03-31 13F Regeneron Pharmaceuticals Option Put 962 -16.85 92,592 -8.88 n/a n/a n/a
2024-02-14 2023-12-31 13F/A Regeneron Pharmaceuticals Option Put 1,157 2.12 101,618 8.98 n/a n/a n/a
2024-02-07 2023-12-31 13F/A Regeneron Pharmaceuticals Option Put 1,157 101,618 n/a n/a n/a
2024-02-07 2023-12-31 13F Regeneron Pharmaceuticals Option Put 1,157 101,618 n/a n/a n/a
2023-11-14 2023-09-30 13F Regeneron Pharmaceuticals Option Put 1,133 43.06 93,241 63.85 n/a n/a n/a
2023-08-09 2023-06-30 13F Regeneron Pharmaceuticals Option Put 792 50.57 56,908 31.67 n/a n/a n/a
2023-05-12 2023-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 526 0.57 43,220 14.54 n/a n/a n/a
2023-02-14 2022-12-31 13F Regeneron Pharmaceuticals Option Put 523 30.42 37,734 36.60 n/a n/a n/a
2022-11-16 2022-09-30 13F/A Regeneron Pharmaceuticals Option Put 401 4.43 27,624 21.69 n/a n/a n/a
2022-11-15 2022-09-30 13F Regeneron Pharmaceuticals Option Put 401 27,624 n/a n/a n/a
2022-08-12 2022-06-30 13F Regeneron Pharmaceuticals Option Put 384 40.15 22,699 18.62 n/a n/a n/a
2022-05-18 2022-03-31 13F/A Regeneron Pharmaceuticals Option Put 274 -38.43 19,137 -31.91 n/a n/a n/a
2022-02-09 2021-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 445 3.01 28,103 7.49 n/a n/a n/a
2021-11-16 2021-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 432 0.00 26,144 8.35 n/a n/a n/a
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 406 22,727 n/a n/a n/a
2021-08-10 2021-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 432 -3.36 24,129 14.09 n/a n/a n/a
2021-05-07 2021-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 447 1.36 21,149 -0.73 n/a n/a n/a
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 441 8.62 21,305 -6.26 n/a n/a n/a
2020-10-30 2020-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 406 40.00 22,727 25.67 n/a n/a n/a
2020-08-06 2020-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 290 -32.24 18,086 -13.46 n/a n/a n/a
2020-05-13 2020-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 428 -46.37 20,899 -30.25 n/a n/a n/a
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 798 17.87 29,963 59.56 n/a n/a n/a
2019-11-07 2019-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 677 7.97 18,780 -4.31 n/a n/a n/a
2019-07-30 2019-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 627 34.55 19,625 2.57 n/a n/a n/a
2019-04-25 2019-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 466 -84.55 19,135 -83.01 n/a n/a n/a
2019-02-12 2018-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 3,016 -6.39 112,648 -13.47 n/a n/a n/a
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 3,222 2.06 130,182 19.53 n/a n/a n/a
2018-07-25 2018-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 3,157 -99.11 108,913 -10.66 n/a n/a n/a
2018-05-11 2018-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 354,000 -40.62 121,903 -45.61 n/a n/a n/a
2018-03-05 2017-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 596,200 10,270.50 224,147 1,323.52 n/a n/a n/a
2018-02-01 2017-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 596,200 224,147 n/a n/a n/a
2017-11-03 2017-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 5,749 2.90 15,746 14.69 n/a n/a n/a
2017-08-03 2017-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 5,587 -1.45 13,729 -54.84 n/a n/a n/a
2017-05-03 2017-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 5,669 340.14 30,401 999.89 n/a n/a n/a
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 1,288 2,764 n/a n/a n/a
2015-05-15 2015-03-31 13F * REGENERON PHARMACEUTICALS COM OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-11 2014-12-31 13F * REGENERON PHARMACEUTICALS COM OPTION Put 450 0.00 2 -90.91 n/a n/a n/a
2014-11-12 2014-09-30 13F * REGENERON PHARMACEUTICALS COM OPTION Put 450 0.00 22 1,000.00 n/a n/a n/a
2014-08-14 2014-06-30 13F/A * REGENERON PHARMACEUTICALS COM OPTION Put 450 0.00 2 -97.01 n/a n/a n/a
2014-08-14 2014-06-30 13F REGENERON PHARMACEUTICALS COM OPTION Put 450 2 n/a n/a n/a
2014-05-13 2014-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 450 0.00 68 -25.56 n/a n/a n/a
2014-04-02 2013-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 450 90 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.